ScholarIQanswers from OpenAlex & ORCID
Lieneke F.M. Ariëns
ResearcherPublications, citations & collaboration network
Lieneke F.M. Ariëns is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Lieneke F.M. Ariëns have?
ScholarIQindexed works
Lieneke F.M. Ariëns has 19 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Lieneke F.M. Ariëns have?
ScholarIQcitation count
Lieneke F.M. Ariëns has 1,096 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Lieneke F.M. Ariëns?
ScholarIQh-index
Lieneke F.M. Ariëns has an h-index of 14 in OpenAlex.
What is the i10-index of Lieneke F.M. Ariëns?
ScholarIQi10-index
Lieneke F.M. Ariëns has an i10-index of 15 in OpenAlex.
What is the ORCID of Lieneke F.M. Ariëns?
ScholarIQorcid
The ORCID for Lieneke F.M. Ariëns is on the source record.
What is the OpenAlex record for Lieneke F.M. Ariëns?
ScholarIQopenalex
The OpenAlex for Lieneke F.M. Ariëns is on the source record.
What are the most-cited papers on Lieneke F.M. Ariëns?
ScholarIQmost cited works
Conjunctivitis occurring in atopic dermatitis patients treated with dupilumab–clinical characteristics and treatment
Andreas Wollenberg, Lieneke F.M. Ariëns, Stephan Thurau, Chantal van Luijk, Marlene Seegräber, Marjolein de Bruin‐Weller
Goblet cell scarcity and conjunctival inflammation during treatment with dupilumab in patients with atopic dermatitis
Daphne S. Bakker, Lieneke F.M. Ariëns, C. van Luijk, Jorien van der Schaft, Judith L. Thijs, Marie L. A. Schuttelaar, Femke van Wijk, Edward F. Knol, Deepak M.W. Balak, Marijke R. van Dijk, Marjolein de Bruin‐Weller
Dupilumab is very effective in a large cohort of difficult‐to‐treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registry
Lieneke F.M. Ariëns, Jorien van der Schaft, Daphne S. Bakker, Deepak M.W. Balak, Margreet L. E. Romeijn, T. Kouwenhoven, Marijke Kamsteeg, Barbara Giovannone, Julia Drylewicz, Cynthia C. A. van Amerongen, Evelien M. Delemarre, Edward F. Knol, Femke van Wijk, Stefan Nierkens, Judith L. Thijs, Marie L. A. Schuttelaar, Marjolein de Bruin‐Weller
Barriers and Facilitators to eHealth Use in Daily Practice: Perspectives of Patients and Professionals in Dermatology
Lieneke F.M. Ariëns, Florine ML Schussler-Raymakers, Cynthia Frima, Annebeth Flinterman, Eefje A. Hamminga, B.W.M. Arents, Carla A.F.M. Bruijnzeel-Koomen, Marjolein de Bruin‐Weller, Harmieke van Os‐Medendorp
Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice: 52-Week results from the Dutch BioDay registry
Lieneke F.M. Ariëns, Jorien van der Schaft, Lotte S. Spekhorst, Daphne S. Bakker, Geertruida L. E. Romeijn, T. Kouwenhoven, Marijke Kamsteeg, Angelique N. Voorberg, Albert J. Oosting, Ilona de Ridder, Annemieke Sloeserwij, Inge Haeck, Judith L. Thijs, Marie L. A. Schuttelaar, Marjolein de Bruin‐Weller